Episode 21: Endo Intl Downgrade to 'B' - Litigation, Generics, and Opioids
b'
S&P Global Ratings analyst Arthur Wong discusses the recent downgrade of Endo International, which took another significant charge for its mesh litigation settlement, while dealing with ongoing pressures in the generic and opioid markets.
'